Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension

Previous research indicates that patient self-measured blood pressure (SMBP) is a cost-effective strategy for improving hypertension (HTN) diagnosis and control. However, it is unknown which specific uses of SMBP produce the most value. Our goal is to estimate, from an insurance perspective, the ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Alejandro, Woods, John, Wozniak, Gregory, Tsipas, Stavros, Rakotz, Michael, Jay, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213192/
https://www.ncbi.nlm.nih.gov/pubmed/34143817
http://dx.doi.org/10.1371/journal.pone.0252701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213192/
https://www.ncbi.nlm.nih.gov/pubmed/34143817
http://dx.doi.org/10.1371/journal.pone.0252701

Ejemplares similares